This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
